Radiation after kidney-sparing surgery for high-risk ureteral cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether adding radiation therapy after surgery that removes only part of the ureter or the entire kidney and ureter helps prevent cancer from coming back in patients who have high-risk features like aggressive cell type or deep tumor invasion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ureteral cancer with high-risk features such as multiple tumors, aggressive cell type (G3), or deep invasion (T2-4).
- You have had surgery to remove part of the ureter or the entire kidney and ureter.
- You are 18 years or older.
- You have had a CT scan of your abdomen and pelvis within the last 4 weeks that shows no cancer spread to other organs or lymph nodes.
- You have not had other cancers in the last 5 years except for non-melanoma skin cancer or ductal carcinoma in situ of the breast.
- You are willing to complete study required tests and follow-ups and to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving radiation therapy before surgery can improve outcomes for people with high-risk upper urinary tract cancer. It aims to see if this approach is safe and effective.
This study compares two treatments for cancer of the kidney pelvis or ureter: radiation therapy (using high-energy beams) versus surgery. It is for people who cannot have surgery for medical reasons and want to see if radiation could be a good alternative.
This trial is testing a kidney-sparing treatment approach for people with high-risk cancer in the kidney or ureter that has not spread. It aims to control the cancer while saving as much of the kidney's function as possible.
This trial is testing whether adding immunotherapy and radiation after surgery can improve outcomes for people with advanced upper tract urothelial cancer (UTUC) who cannot have chemotherapy. It compares the combination to surgery alone.
This trial tests a combination of two drugs and radiation therapy given before surgery for high-risk upper tract urothelial cancer. The goal is to see if this approach can improve outcomes for patients who are eligible for surgery.
This trial compares combining immunotherapy with radiation versus standard chemotherapy for patients with high-risk upper urinary tract cancer after surgery. It aims to see if the new combination works better at preventing cancer from coming back.
Hear when a new Locally Advanced trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.